Clinical Trial of Chinese Formula AMP-1915 on Metabolic Syndrome
Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the Chinese formula AMP-1915 has effect on
Metabolic Syndrome (MS) in MS patients. Half of patients received AMP-1915, while the other
half received placebo.
Phase:
Early Phase 1
Details
Lead Sponsor:
Shanghai University of Traditional Chinese Medicine